ivosidenib,azacitidine
servier
['aza ', 'cll', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', '+aza', 'agile']
starting the 617 aml #ash22 session of today with prof dohner presenting the updated results of the agile study: cr 73% relapse driven by non idh1-mutant clones 
MD @ClevelandClinic @unitorvergata | Lymphoma survivor#Resilient | MDS/AML/APL/Bone marrow failure syndromes| Member @TheEBMT_Trainee | Opinions are my own